Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
मुख्य लेखक: | Forbes, E |
---|---|
अन्य लेखक: | Hill, A |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
2011
|
विषय: |
समान संसाधन
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
द्वारा: Kapulu, MC
प्रकाशित: (2014) -
Developing novel blood-stage malaria vaccines
द्वारा: Douglas, AD
प्रकाशित: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
द्वारा: Bauza, K
प्रकाशित: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
द्वारा: de Cassan, S
प्रकाशित: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
द्वारा: Elias, SC
प्रकाशित: (2014)